Stories
Jeena Sikho Lifecare: ₹510 Share, ₹1,000 Target, 97% Return Expected; Brokerage Recommends BUY.
C
CNBC Awaaz•21-09-2026, 17:50
Jeena Sikho Lifecare: ₹510 Share, ₹1,000 Target, 97% Return Expected; Brokerage Recommends BUY.
- •Choice Institutional Equities maintains a 'BUY' rating for Jeena Sikho Lifecare with a target price of ₹1,000, indicating a potential 97% return from the current ₹507 level.
- •The company aims to expand to 7,000-10,000 operational beds and achieve 30% annual revenue growth within the next 3-5 years.
- •New hospital projects are planned for Lucknow, Ahmedabad, Patna, Kolkata, and Pune, with capacity expansion also underway in Mumbai.
- •Jeena Sikho Lifecare has initiated international expansion in the UAE and is actively exploring acquisition opportunities.
- •Choice estimates a CAGR of 33.6%, 34.9%, and 39.4% for Revenue, EBITDA, and PAT, respectively, during FY26-29.
Key Questions Answered
Choice Institutional Equities has maintained a BUY rating on Jeena Sikho Lifecare with a target price of ₹1,000, which indicates a potential return of approximately 97% from its closing level near ₹507.
The management has reiterated its goal to reach 7,000 to 10,000 operational beds over the next 3 to 5 years, with operational beds expected to hit around 3,000 in the next 3 to 4 months.
Choice Institutional Equities estimates a CAGR of 33.6% for revenue, 34.9% for EBITDA, and 39.4% for PAT between FY26 and FY29, with revenue projected to grow from ₹8.01 billion to ₹19.11 billion.
